Furthermore, upon antigen encounter, amplification of 22894 TCR-transduced CD8+ T cells was significantly higher when compared to that of the CD8+ T cells modified with 5934 Rac1-derived TCR, despite comparable T cell transduction rates and comparable recognition of Rac1P29S+ tumor cells in vitro. This evidence concerns the gene CD8A and neoplasm.